What Happened
Clarest, LLC (Clarest Health), ProCare LTC New England, and ProCare LTC Pharmacy of Connecticut paid $499,525 in August 2023 to resolve allegations that they violated the Controlled Substances Act. The government alleged that between September 2020 and September 2022, the Cheshire pharmacy distributed controlled substances for long-term care facilities' emergency box stock to practitioners not registered to dispense them on 96 occasions. It also alleged failures to record required information on DEA Form 222 order forms and to reject improper forms. ProCare agreed to a three-year Corrective Action Plan with the DEA.
“have paid $499,525 to resolve allegations that they violated the civil provisions of the Controlled Substances Act”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.